Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
NCT07764133
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian CancerUniversity of Tennessee Graduate School of MedicineRecruiting
NCT07764133Recruiting
—
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation a...University of Tennessee G...
NCT07762365
Brain Stimulation Paired With Structured Reading Instruction in Children With DyslexiaGeneral Neuro Inc.RecruitingNot Applicable
NCT07762365Recruiting
Not Applicable
Brain Stimulation Paired With Structured Reading Instruction in Children With Dy...General Neuro Inc.
NCT07763587
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation of Acupuncture Collaborative Management RegimenFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineNot Yet RecruitingNot Applicable
NCT07763587Not Yet Recruiting
Not Applicable
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Ben...First Teaching Hospital o...
NCT07764250
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training in Elderly With Mild and Moderate Cognitive ImpairmentShifa Tameer-e-Millat UniversityRecruitingNot Applicable
NCT07764250Recruiting
Not Applicable
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training i...Shifa Tameer-e-Millat Uni...
NCT07762794
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting in Patients With Extremity Arterial Injury Requiring Urgent RepairHumacyte, Inc.Not Yet RecruitingPhase 4
NCT07762794Not Yet Recruiting
Phase 4
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real Worl...Humacyte, Inc.
NCT07763600
Effect of Anesthesia Type on Surgeon Workload During Endoscopic Kidney Stone SurgeryMalatya Governor Research HospitalNot Yet Recruiting
NCT07763600Not Yet Recruiting
—
Effect of Anesthesia Type on Surgeon Workload During Endoscopic Kidney Stone Sur...Malatya Governor Research...
NCT07764328
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Balance in Women Who Suffer From Self-reported PCOS Symptoms.Mila Mend Inc.RecruitingNot Applicable
NCT07764328Recruiting
Not Applicable
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Bal...Mila Mend Inc.
NCT07764380
Epigenetic and Cortisol Level Reflections of Maternal Stress During PregnancyKahramanmaras Sutcu Imam UniversityRecruitingNot Applicable
NCT07764380Recruiting
Not Applicable
Epigenetic and Cortisol Level Reflections of Maternal Stress During PregnancyKahramanmaras Sutcu Imam...
NCT07763509
Calcium-Rich Food Versus Calcium Carbonate for Bone HealthCornell UniversityNot Yet RecruitingNot Applicable
NCT07763509Not Yet Recruiting
Not Applicable
Calcium-Rich Food Versus Calcium Carbonate for Bone HealthCornell University
NCT07764185
Caring Recharge Project for Caregivers of Individuals With Alzheimer's DiseasePhotozig, Inc.Not Yet RecruitingPhase 2
NCT07764185Not Yet Recruiting
Phase 2
Caring Recharge Project for Caregivers of Individuals With Alzheimer's DiseasePhotozig, Inc.
NCT07764211
Multimodal Cohort Study of Generalized Anxiety DisorderShanghai Mental Health CenterNot Yet Recruiting
NCT07764211Not Yet Recruiting
—
Multimodal Cohort Study of Generalized Anxiety DisorderShanghai Mental Health Ce...
NCT07763405
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hospital of Nanchang UniversityNot Yet RecruitingPhase 4
NCT07763405Not Yet Recruiting
Phase 4
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hosp...
NCT07763418
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal FunctionBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07763418Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participan...Bristol-Myers Squibb
NCT07764341
Supervised Exercise During Neoadjuvant Chemotherapy for Breast CancerBahrain Oncology CenterNot Yet RecruitingNot Applicable
NCT07764341Not Yet Recruiting
Not Applicable
Supervised Exercise During Neoadjuvant Chemotherapy for Breast CancerBahrain Oncology Center
NCT07762222
Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chronic Post-thrombotic Venous UlcersAin Shams UniversityRecruitingNot Applicable
NCT07762222Recruiting
Not Applicable
Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chr...Ain Shams University
NCT07762625
Couple-Coordinated Lifestyle Intervention for Women With a History of Gestational Diabetes MellitusCentral South UniversityNot Yet RecruitingNot Applicable
NCT07762625Not Yet Recruiting
Not Applicable
Couple-Coordinated Lifestyle Intervention for Women With a History of Gestationa...Central South University
NCT07762027
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionAssembly BiosciencesNot Yet RecruitingPhase 2
NCT07762027Not Yet Recruiting
Phase 2
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Part...Assembly Biosciences
NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762716Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTr...BreakBio Corp
Result Breakdown
Not yet recruiting13 (65%)
Recruiting6 (30%)
Completed1 (5%)
not_applicable10 (50%)
Not Specified3 (15%)
Phase 42 (10%)
Phase 22 (10%)
Phase 12 (10%)
Phase 31 (5%)